Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001889203 | SCV002157709 | uncertain significance | Pityriasis rubra pilaris; Psoriasis 2 | 2022-08-09 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 1389355). This variant has not been reported in the literature in individuals affected with CARD14-related conditions. This variant is present in population databases (rs772155622, gnomAD 0.005%). This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 830 of the CARD14 protein (p.Val830Ala). |